AKT1 and Parkinson disease: Evidence shows that AKT and GSK3β are abnormally expressed in PD, and AKT inhibits dopaminergic neuron apoptosis and oxidative stress by increasing the GSK3β phosphorylation of Ser9 and decreasing p65 phosphorylation [24,25].